Core Viewpoint - The company, Nopson (002215), plans to raise up to 1.45 billion yuan through a private placement to expand its blueberry cultivation and enhance its research capabilities in the small berry sector, thereby strengthening its position in the fresh produce market [1][2][3] Group 1: Fundraising and Investment Plans - The company intends to issue shares to no more than 35 specific investors, with the total number of shares not exceeding 30% of the pre-issue total share capital [1] - The funds will be allocated as follows: 1.1 billion yuan for expanding the blueberry base, 150 million yuan for the small berry international research center, and 200 million yuan for working capital [1][2] Group 2: Blueberry Business Expansion - The blueberry base expansion project will involve the establishment of approximately 13,500 acres of blueberry farms in Yunnan, with a total investment of 1.221 billion yuan and a construction period of two years [1][2] - The company has invested over 4 billion yuan in the blueberry industry since entering the market in 2021, establishing over 60 farms and more than 40 cold chain processing centers across multiple cities in Yunnan [2] Group 3: Market Potential and Competitive Advantage - The national blueberry production is projected to reach 780,000 tons in 2024, with demand expected to exceed 1 million tons in 2025, indicating a market size of approximately 50 billion yuan [3] - The company benefits from Yunnan's climatic advantages for winter and spring blueberry production, positioning it well to meet high seasonal demand during festive periods [3] - The fundraising will also improve the company's financial structure, with a current debt ratio of 64.95%, enhancing its risk resilience [3]

Group 1 - The core point of the article is that Noposion (002215.SZ) plans to issue A-shares to specific investors, aiming to raise up to 1.45 billion yuan for various projects [1] - The company intends to issue shares to no more than 35 specific investors, with the issuance price set at no less than 80% of the average trading price over the last 20 trading days [1] - The total number of shares to be issued will not exceed 30% of the company's total share capital prior to the issuance, amounting to a maximum of 302 million shares [1] Group 2 - The raised funds will be allocated to the expansion of blueberry bases, the construction of an international research and development center for small berries, and to supplement working capital [1]

Group 1 - The core point of the article is that Noposion (002215.SZ) plans to issue A-shares to specific investors, aiming to raise up to 1.45 billion yuan for various projects [1] - The company intends to issue shares to no more than 35 specific investors, with the issuance price set at no less than 80% of the average trading price over the last 20 trading days [1] - The total number of shares to be issued will not exceed 30% of the company's total share capital prior to the issuance, amounting to a maximum of 302 million shares [1] Group 2 - The raised funds will be allocated to the expansion of blueberry bases, the construction of an international research and development center for small berries, and to supplement working capital [1]

Core Viewpoint - Noposion (002215.SZ) plans to raise a total of no more than 1.45 billion yuan through a private placement of shares, which will be used for the expansion of blueberry bases, the construction of a small berry international R&D center, and to supplement working capital [1] Group 1 - The company intends to issue shares to specific investors to raise funds [1] - The total amount targeted for fundraising is capped at 1.45 billion yuan [1] - The funds will be allocated to specific projects including the expansion of blueberry bases and the establishment of a small berry international R&D center [1]

Group 1 - The company Nopson (SZ 002215) announced a plan to issue A-shares to specific investors, with the total number of shares not exceeding 30% of the total share capital prior to the issuance, approximately 302 million shares [1] - The issuance aims to raise up to 1.45 billion yuan, with funds allocated for a blueberry base expansion project, a small berry international R&D center, and working capital [1] - The revenue composition for Nopson in the first half of 2025 shows that the industry chain business accounts for 49.42%, pesticide formulation business for 40.45%, and the Tian Tian Quan business for 10.13% [1] Group 2 - As of the report, Nopson's market capitalization is 11.6 billion yuan [2] - The company has faced regulatory scrutiny, with the China Securities Regulatory Commission initiating an investigation due to a significant loss exceeding 100 million yuan shortly after its IPO [2] - The company's primary customer has reduced procurement due to self-supply, impacting its core product performance [2]

Group 1 - The company, Noposion (002215), announced on November 25 that it plans to issue A-shares to specific investors to raise funds not exceeding 1.45 billion yuan [1] - The raised funds will be allocated to the expansion of blueberry bases, the construction of an international research and development center for small berries, and to supplement working capital [1]

Core Viewpoint - Noposion (SZ 002215) announced a temporary board meeting on November 24, 2025, to discuss the stock issuance plan for 2025 [1] Group 1: Financial Performance - For the first half of 2025, Noposion's revenue composition is as follows: 49.42% from supply chain business, 40.45% from pesticide formulation business, and 10.13% from the Tiantian Circle business [1] - As of the report, Noposion's market capitalization is 11.6 billion yuan [1] Group 2: Regulatory Issues - The company is under investigation by the China Securities Regulatory Commission (CSRC) due to a significant loss exceeding 100 million yuan shortly after its IPO, with its main customer reducing purchases for self-use [1]

证券代码：002215 证券简称：诺普信 深圳诺普信作物科学股份有限公司 2025 年度向特定对象发行 A 股股票预案 二〇二五年十一月 1 公司声明 1、公司及董事会全体成员保证本预案不存在虚假记载、误导性陈述或重大 遗漏，并对本预案的真实性、准确性、完整性承担个别和连带的法律责任。 2、本预案按照《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司证券发行注册管理办法》等法规及规范性文件的要求编制。 3、本次向特定对象发行 A 股股票完成后，公司经营与收益的变化由公司自 行负责；因本次向特定对象发行 A 股股票引致的投资风险由投资者自行负责。 4、本预案是公司董事会对本次向特定对象发行 A 股股票的说明，任何与之 相反的声明均属不实陈述。 5、投资者如有任何疑问，应咨询自己的股票经纪人、律师、专业会计师或 其它专业顾问。 本部分所述的词语或简称与本预案"释义"中所定义的词语或简称具有相同 的含义。 1、本次向特定对象发行股票符合《公司法》《证券法》《发行注册管理办 法》等法律、行政法规、部门规章及规范性文件的规定，公司具备向特定对象发 行股票的各项条件。 2、本次向特定对象发行 A 股股票相关事项 ...

深圳诺普信作物科学股份有限公司 2025 年度向特定对象发行 A 股股票 方案论证分析报告 二〇二五年十一月 1 为满足公司经营战略的实施和业务发展的资金需求，进一步增强公司的资本 实力和盈利能力，深圳诺普信作物科学股份有限公司（以下简称"公司"、"诺 普信"）拟向特定对象发行A股股票，根据《中华人民共和国证券法》（以下简 称"《证券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司证券发行注册管理办法》（以下简称"《注册管理办法》"）和《〈上 市公司证券发行注册管理办法〉第九条、第十条、第十一条、第十三条、第四十 条、第五十七条、第六十条有关规定的适用意见——证券期货法律适用意见第18 号》（以下简称"《证券期货法律适用意见第18号》"）等有关法律、法规和规 范性文件和《公司章程》的规定，公司编制了《深圳诺普信作物科学股份有限公 司2025年度向特定对象发行A股股票方案论证分析报告》。 证券代码：002215 证券简称：诺普信 本论证报告如无特别说明，相关用语具有与《深圳诺普信作物科学股份有限 公司2025年度向特定对象发行A股股票预案》中相同的含义。 一、本次向特定对象发行 A 股 ...

深圳诺普信作物科学股份有限公司公告 关于向特定对象发行 A 股股票预案披露的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）拟向特定对象发行 A 股股票，本次向特定对象发行 A 股股票的相关议案已经 2025 年 11 月 24 日 召开的公司第七届董事会第九次会议（临时）审议通过。《深圳诺普信作物科学 股份有限公司 2025 年度向特定对象发行 A 股股票预案》（以下简称"《预案》"） 具体内容已同日披露在中国证监会指定信息披露网站上，敬请投资者注意查阅。 证券代码：002215 证券简称：诺普信 公告编号：2025-057 深圳诺普信作物科学股份有限公司 《预案》的披露事项不代表审核、注册机关对本次向特定对象发行股票相关 事项的实质性判断、确认、批准或同意注册，《预案》所述本次向特定对象发行 A 股股票相关事项的生效和完成尚需公司股东会审议通过、深圳证券交易所审核 通过及中国证监会同意注册后方可实施，敬请广大投资者注意投资风险。 特此公告。 深圳诺普信作物科学股份有限公司董事会 二〇二五年十一月二十六 ...